Pharmacology of the taxanes

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The taxanes paclitaxel and docetaxel are structurally similar, but they have different pharmacologic characteristics. Both bind to the β-subunit of tubulin and affect microtubule polymerization. The cell cycle phases affected by the drugs are distinctly different; paclitaxel inhibits cell cycle traverse at the G2-M phase junction, and docetaxel produces maximum cell killing against cells in S phase. The drugs both undergo hepatic metabolism; however, the specific cytochrome P-450 (CYP) enzymes responsible for hydroxylation are CYP 2C8 for paclitaxel and CYP 3A4 for docetaxel. The cytotoxic effects of the taxanes are schedule dependent. For both drugs, longer durations of exposure increase cytotoxicity. Studies are being conducted to determine if prolonged exposure in cancer cell lines increases response rates in patients with sensitive tumors. The distinct mechanistic and metabolic differences between paclitaxel and docetaxel may influence clinical efficacy and safety in patients with cancer.

Original languageEnglish (US)
JournalPharmacotherapy
Volume17
Issue number5 II SUPPL.
StatePublished - Sep 1997

Fingerprint

docetaxel
Taxoids
Paclitaxel
Pharmacology
Cytochrome P-450 Enzyme System
Cell Cycle
Pharmaceutical Preparations
Neoplasms
G2 Phase
Hydroxylation
Tubulin
Patient Safety
S Phase
Microtubules
Polymerization
Cell Division
Appointments and Schedules
Cell Line
Liver

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacology of the taxanes. / Dorr, Robert T.

In: Pharmacotherapy, Vol. 17, No. 5 II SUPPL., 09.1997.

Research output: Contribution to journalArticle

Dorr, RT 1997, 'Pharmacology of the taxanes', Pharmacotherapy, vol. 17, no. 5 II SUPPL..
Dorr, Robert T. / Pharmacology of the taxanes. In: Pharmacotherapy. 1997 ; Vol. 17, No. 5 II SUPPL.
@article{203eb7914ea342a185f0c30ab7e9708a,
title = "Pharmacology of the taxanes",
abstract = "The taxanes paclitaxel and docetaxel are structurally similar, but they have different pharmacologic characteristics. Both bind to the β-subunit of tubulin and affect microtubule polymerization. The cell cycle phases affected by the drugs are distinctly different; paclitaxel inhibits cell cycle traverse at the G2-M phase junction, and docetaxel produces maximum cell killing against cells in S phase. The drugs both undergo hepatic metabolism; however, the specific cytochrome P-450 (CYP) enzymes responsible for hydroxylation are CYP 2C8 for paclitaxel and CYP 3A4 for docetaxel. The cytotoxic effects of the taxanes are schedule dependent. For both drugs, longer durations of exposure increase cytotoxicity. Studies are being conducted to determine if prolonged exposure in cancer cell lines increases response rates in patients with sensitive tumors. The distinct mechanistic and metabolic differences between paclitaxel and docetaxel may influence clinical efficacy and safety in patients with cancer.",
author = "Dorr, {Robert T}",
year = "1997",
month = "9",
language = "English (US)",
volume = "17",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "5 II SUPPL.",

}

TY - JOUR

T1 - Pharmacology of the taxanes

AU - Dorr, Robert T

PY - 1997/9

Y1 - 1997/9

N2 - The taxanes paclitaxel and docetaxel are structurally similar, but they have different pharmacologic characteristics. Both bind to the β-subunit of tubulin and affect microtubule polymerization. The cell cycle phases affected by the drugs are distinctly different; paclitaxel inhibits cell cycle traverse at the G2-M phase junction, and docetaxel produces maximum cell killing against cells in S phase. The drugs both undergo hepatic metabolism; however, the specific cytochrome P-450 (CYP) enzymes responsible for hydroxylation are CYP 2C8 for paclitaxel and CYP 3A4 for docetaxel. The cytotoxic effects of the taxanes are schedule dependent. For both drugs, longer durations of exposure increase cytotoxicity. Studies are being conducted to determine if prolonged exposure in cancer cell lines increases response rates in patients with sensitive tumors. The distinct mechanistic and metabolic differences between paclitaxel and docetaxel may influence clinical efficacy and safety in patients with cancer.

AB - The taxanes paclitaxel and docetaxel are structurally similar, but they have different pharmacologic characteristics. Both bind to the β-subunit of tubulin and affect microtubule polymerization. The cell cycle phases affected by the drugs are distinctly different; paclitaxel inhibits cell cycle traverse at the G2-M phase junction, and docetaxel produces maximum cell killing against cells in S phase. The drugs both undergo hepatic metabolism; however, the specific cytochrome P-450 (CYP) enzymes responsible for hydroxylation are CYP 2C8 for paclitaxel and CYP 3A4 for docetaxel. The cytotoxic effects of the taxanes are schedule dependent. For both drugs, longer durations of exposure increase cytotoxicity. Studies are being conducted to determine if prolonged exposure in cancer cell lines increases response rates in patients with sensitive tumors. The distinct mechanistic and metabolic differences between paclitaxel and docetaxel may influence clinical efficacy and safety in patients with cancer.

UR - http://www.scopus.com/inward/record.url?scp=0030793724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030793724&partnerID=8YFLogxK

M3 - Article

C2 - 9322876

AN - SCOPUS:0030793724

VL - 17

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 5 II SUPPL.

ER -